13
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Occurrence of Myeloma in a Chronic Lymphocytic Leukemia Patient After Response to Differentiation Therapy with Interleukin-4

, , &
Pages 617-619 | Received 10 Mar 1996, Published online: 01 Jul 2009

References

  • Foon K. A., Thiruvengadam R., Saven A., Bernstein Z. P., Gale R. P. Genetic relatedness of lymphoid malignancies: Transformation of chronic lymphocytic leukemia as a model. Annals of Internal Medicine 1993; 119: 63–73
  • Offit K., Louie D. C., Parsa N. Z., Noy A., Chaganti R. S. K. Del(7) (q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 1995; 86: 2365–2370
  • Jansen J. H., Fibbe W. E., Willemze R., Kluin-Nelemans J. C. Interleukin-4: A regulatory protein. Blut 1990; 60: 269–274
  • Taylor C. W., Grogan T. M., Salmon S. E. Effects of interleukin-4 on in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114–1118
  • Luo H., Biron G., Rubio M., Delespesse G., Sarfati M. IL-4 displays potent in vitro antiproliferative activity in B chronic lymphocytic leukemia. Blood 1990; 76 (suppl).: 298
  • Maher D., Boyd A., McKendrick J., Begley G., Lieschke M., Green M., Fox R., Rallings M., Bonnem E., Morstyn G. Rapid response of B-cell malignancies induced by interleukin-4. Blood 1990; 76 (suppl): 152
  • Frieman J., Estrov Z., Itoh K., O'Brien S., Kantarjian H., Keating M., Yeomans A., Hunter C., Gutterman J., Markowitz A. Phase 1 studies of recombinant human interleukin-4 in patients with hematologic malignancies. Blood 1990; 76 (suppl): 93
  • Defrance T., Vanbervliet B., Pene J., Banchereau J. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM. Journal of Immunology 1988; 141: 2000–2005
  • Juliusson G., Elmhorn-Rosenborg A., Liliemark J. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. New England Journal of Medicine 1992; 327: 1056–1061
  • Dimopoulos M. A., Kantarjian H. M., Estey E. H., Alexanian R. 2-Chlorodeoxyadenosine in treatment of myeloma. Blood 1992; 79: 1626
  • Nagourney R. A., Evans S. S., Messenger J. C., Su Y. Z., Wiesenthal L. M. 2-Chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms. British Journal of Cancer 1993; 67: 10–14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.